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Abstract 34 
Limb malformations are amongst the most common and visible birth effects. Causes have been 35 
purported to include genetic aberrations as well as teratogens, such as thalidomide. Here we 36 
review the evidence for vascular disruption in the genesis of limb malformations through 37 
abnormal arterial transitioning and from events such as amniocentesis, uterine constriction, and 38 
through teratogen exposure. We use several clinical and experimental examples and highlight the 39 
need to understand more about the role the vascular system plays in the molecular mechanisms 40 
underpinning normal limb development. 41 
 42 
Blood vessel formation and development 43 
Blood vessels are essential for embryogenesis as well as for normal physiological function 44 
throughout life. In the embryo the first primitive vessels are formed by vasculogenesis, where 45 
endothelial cell precursors congregate and form vascular tubes for blood cells to pass through. 46 
This initial network is expanded upon through angiogenesis, where new vessels form through the 47 
proliferation and migration of endothelial cells and vascularize previously avascular tissues 48 
(Figure 1) [1]. Many molecules are involved in angiogenesis and one of the main triggers of 49 
angiogenesis is hypoxia which stimulates the expression of Vascular Endothelial Growth Factor 50 
to cause the proliferation and migration of endothelial cells into previously avascular tissue [1-3]. 51 
In the rapidly developing early embryo, angiogenesis occurs in the majority of tissues to ensure 52 
good oxygen and nutrient supply and the removal of waste products. Vessels can recruit a 53 
smooth muscle coating which stabilizes the vessel and also maintains blood pressure, and until 54 
the loss of the smooth muscle coat, the vessel then undergoes quiescence (Figure 1). 55 
 56 
Limb development and vascularisation of the developing limb 57 
In the developing human embryo, the upper limbs form around day 26 (approx. week 3.7) after 58 
fertilization followed 24hrs later by the lower limbs [4]. The limbs grow out from the body under 59 
the control of specialized signaling regions, specifically the Zone of Polarising Activity (ZPA) 60 
and the Apical Ectodermal Ridge (AER). These two regions in particular signal to the 61 
mesenchyme to induce mesenchymal cell proliferation and limb outgrowth as well as control 62 
differentiation of the bones and tissues of the limbs (Figure 2A) [1, 5]. As the limbs grow out 63 
from the body, the multitude of tissues including muscle, tendon, nerve and bones of the limb 64 
differentiates in a proximal to distal manner, that is the humerus/femur is specified and laid down 65 
before the radius/fibula and ulna/tibia and finally the digits (Figure 2A). The vessel patterns 66 
change accordingly (Figure 2B). Vessel regression in the areas where the long bones and the 67 
future digits form occurs and this process also marks a change in the vessel pattern to the adult 68 
state (Figure 2B). By around day 56 (approx. week 8) human limbs are fully complete with 69 
fingers/toes etc. 70 
 71 
The molecular and morphological events that underlie limb development and some limb 72 
malformations are becoming clearer and have largely been ascertained from animal models 73 
particularly the chicken and mouse (Figure 2A) [5-8]. Yet, the role of the rapidly changing 74 
vasculature in the molecular and mechanistic events underlying limb development are largely 75 
unknown. 76 
 77 
Most of our understanding of limb vascularization has come from animal model systems and 78 
studies in human embryos/fetuses from the beginning of the 20
th
 century [9, 10]. There are some 79 
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differences in the arterial vascularization of the upper and lower limbs. Following the initiation 80 
of limb development, the main artery supplying the upper limb buds is the subclavian artery and 81 
from this a capillary network rapidly forms (via angiogenesis) throughout the outgrowing limb 82 
bud (Figure 2B) [1, 3, 11].  As limb development proceeds the subclavian artery name changes 83 
to become the brachial artery in the upper limb. The brachial artery itself later gives rise to the 84 
ulnar and radial arteries in the forearms. In the lower limbs, arterial vascularization also proceeds 85 
through angiogenesis but is a little more complicated. Initially primitive arteries from the 86 
umbilical artery traverse the forming limb bud as the axial and external iliac arteries. The 87 
external iliac artery eventually becomes the femoral artery, supplying the upper leg. The axial 88 
artery traverses the outgrowing leg bud to supply the distal regions of the leg bud and further 89 
divides into the fibular (peroneal) arteries (Figure 3). As the leg bud develops, there is further 90 
splitting of the femoral artery to produce further arterial supply to the forming bones of the limbs 91 
(Figure 3).  92 
In addition, there is also vessel regression as well as formation of composite arteries. The fibular 93 
(peroneal artery), which primarily provides the blood supply to the fibula, is one such composite 94 
artery; it contains four elements/segments of three earlier embryonic arteries, which have 95 
undergone repeated rounds of angiogenesis and stabilization to achieve the adult configuration 96 
(Figure 3) [9, 10, 12].  97 
 98 
Embryonic to adult arterial transition 99 
Elegant analyses in human embryos have demonstrated that, in early limb buds, a capillary 100 
network is evident. As development proceeds, the vascular pattern differentiates into defined 101 
vessels initially in the proximal tissue and then finally in the distal tissue, where the digits form 102 
last (Figure 3) [9, 10, 13-16]. Approximately five weeks after fertilization, single axial arteries of 103 
both the upper and lower extremities begin the transition to more complex arterial patterns 104 
(Figure 3). The arterial transitions coincide with the long bone transitions from  mesenchymal 105 
primordia (anlage) to chondral and then osseous structures. Arterial alterations occur prior to and 106 
during the organization of the muscles, tendons and nerves but after specification/patterning of 107 
the limb is completed [17].  The upper and lower human limb embryonic arterial transitions have 108 
been completed prior to the 8
th
 week of development, resulting in the adult arterial pattern 109 
(Figure 3) [9, 10 13, 14, 18].  110 
 111 
In the chicken embryo the transition of the arterial pattern of the limbs from embryonic to mature 112 
state has occurred by approximately day 8 of development. As in the the human embryo, the 113 
arterial transitions occur during and after the specification and patterning of the bony elements 114 
has occurred. The arterial transition likely allows the bones of the limb to form correctly and in 115 
the correct positions [11, 19]. Much of our understanding of the processes of limb 116 
vascularization has come from studying chicken limb development [1, 2, 11, 19]. Unlike vessels 117 
in other regions of the chicken embryo, the early developing limb vascular network remains 118 
devoid of vascular smooth muscle cells, which lend protection and support to the vessels. Not 119 
until relatively late in limb development, after the adult vascular pattern has started to become 120 
established are vascular smooth muscle cells seen upon limb vessels (Figure 2B) [11, 20]. 121 
Indeed, the brachial artery starts to recruit smooth muscle first, in chicken embryos from around 122 
HH St25 (E5; about 2.5 days after limb development has started, which is relatively late in 123 
development as the limbs buds are well advanced in outgrowth) (Figure 2A). Other vessels only 124 
start recruiting smooth muscle much later in development [11, 20]. By comparison, vessels in 125 
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other regions of the embryo, including the head, contain vascular smooth muscle coats by these 126 
stages [1, 20, 21]. Smooth muscle protects the vessel and prevents angiogenesis. In order for 127 
angiogenesis to re-occur, the smooth muscle coat needs to be lost [1]. Since the developing limbs 128 
are rapidly growing and changing, the developing limb requires a vasculature that adapts to the 129 
changing environment quickly; thus, a smooth muscle coat would be an obstacle to early 130 
development. Absence of the smooth muscle coat presumably permits rapid changes in limb 131 
outgrowth to occur. However, this also makes the vessels more susceptible to potential injury 132 
and damage [1, 20]. 133 
 134 
Embryonic to adult arterial transition failure and limb defects 135 
Whilst there may be a variation of limb arterial branching patterns in up to 20% of normal adult 136 
humans [13], a failure of correct vessel patterning or a failure of the embryo to adult vascular 137 
transition has been associated with limb defects in humans [12, 22-27] and in animal models [20, 138 
28-31].  139 
 140 
Indeed, through radiographic and pathologic analyses of dysmorphic human lower limbs, the 141 
combined associations of reduction or absence of the proximal femur [22, 32], the fibula [33]  142 
and midline metatarsals [23] suggests the possibility of a temporal and anatomic linkage of the 143 
skeletal changes to failure of embryonic arterial transition, when the long bones are first forming 144 
[9, 10, 12, 15, 18]. Arteriography of a series of such affected limbs further revealed abnormal 145 
arterial patterns, which have demonstrated persistence of primitive embryologic arteries, absence 146 
of one of the normal adult arteries and failure of formation of the plantar arch of the foot [12, 32-147 
35].  148 
 149 
For example, some cases of congenital fibular deficiency (Figure 4A-C) [12]  and radial aplasia 150 
[36] have been described indicating the vascular pattern of the limbs appears to be intermediate 151 
between an embryonic and adult state, suggesting the long bones might not form or might form 152 
incorrectly due to the misplacement or mis-positioning of the vessels. Furthermore, the foot is 153 
typically supplied with three arteries, the posterior tibial, anterior tibial and the fibular (peroneal) 154 
(Figure 3B). In the debilitating condition clubfoot, where the foot points downward, toes are 155 
turned inward and the bottom of the foot, that would normally be walked on is twisted inward, 156 
the anterior tibial artery is most consistently reduced in length in the most severely deformed 157 
limbs and absent in the distal foot. The lack of alternative arterial pathways has been proposed to 158 
explain why the foot ‘clubs’ in such cases (Figure 4D) [17, 24, 35, 37, 38]. In contrast, in cases 159 
of the congenital vertical talus deformity, where the foot is pointed upwards, rigidly, causing the 160 
toes to point up and out with loss of the arch of the foot, the posterior tibial artery is most 161 
consistently significantly reduced or sometimes missing [24, 34, 35, 38]. Similarly, arteriography 162 
of the limbs of children with proximal femoral focal deficiency (PFFD; congenitally short limb), 163 
where the femur may be significantly reduced in length and can vary morphologically from just a 164 
distal remnant of the femur to an almost normal sized femur, has revealed distinctly consistent 165 
arterial changes in a majority of the affected limbs [32]. The changes may include reduction of 166 
the diameter and length of the femoral arteries and/or preservation of the primitive sciatic 167 
(ischiadic) artery [32].  168 
 169 
An abnormal arterial pattern in the developing limb could put the limb at risk for subsequent 170 
malformation as, for example, there may be a reduced potential for collateral vascular circulation 171 
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resulting in tissue damage or loss. Conditions that antagonise blood flow through the remaining 172 
arteries could then lead to tissue damage. This tissue damage could, in turn, interfere with the 173 
developmental specification or differentiation of limb structures, leading to bony and/or soft 174 
tissue abnormalities [12, 17, 24, 26, 33, 37].  175 
 176 
Timing of arterial dysgenesis 177 
Limb development and arterial transition occur between 5 and 8 weeks of human embryonic 178 
development. This coincides with several periods of very rapid growth, considering that the 179 
crown rump length of 10 mm at 5½ weeks grows to 20 mm at 7 weeks, thus effectively doubling 180 
in length over a ten day period. The next most significant period of growth occurs between 7 and 181 
8 weeks, over a seven day period, when the embryo enlarges from a crown rump length of 20 182 
mm to a crown rump length of 30 mm. That is a 50% enlargement over a seven day period [4, 183 
39]. During these times, the outgrowth of the upper and lower extremities is rapidly progressing, 184 
after the specification of the limbs has begun and while the embryonic arterial alterations are 185 
occurring [4, 12, 17, 37, 39]. Since the critical period for the initiation of bone development, 186 
beginning as mesenchymal condensations, occurs subsequent to the fifth week of embryonic life,  187 
coinciding with the time that the adult arterial pattern of vessels is emerging, it is possible that 188 
both the arterial and skeletal systems simultaneously are mutually vulnerable to teratogenic 189 
insults. Thus, the maldevelopment of the bones and the embryonic arterial pattern may be 190 
intimately related [23, 33]. The evidence of embryonic arterial dysgenesis in association with a 191 
variety of skeletal malformations and deletions has provided an explanation for the timing, 192 
pathogenesis and distribution of some limb malformations. 193 
 194 
Indeed, comparisons of the estimates of the upper femoral vs. lower leg dysmorphologies 195 
suggest that the estimated timings of the respective arterial embryonic dysgeneses are associated 196 
with the skeletal dysmorphologies observed. These findings are consistent with a progressively 197 
more distal model of arterial development, after the completion of limb specification [9, 10, 12, 198 
17, 18, 23, 32, 37]. Indeed, the critical time for connection between the femoral artery and the 199 
sciatic (ischiadic) artery in the femoral region of the lower extremity has been estimated to occur 200 
between the 12 and 14 mm stages of embryonic development (approximately week 6) (Figure 201 
3B) [9, 10, 32]; the critical time for arterial changes of the more distal part of the lower extremity 202 
in the tibial and fibular region has been estimated to occur between the 19 and 22 mm stages of 203 
embryonic development (approximately week 7) (Figure 3B) [12, 23]. Hence many limb 204 
malformations may be interpreted as post-specification events, which occur after the bony 205 
elements have been specified but which are then damaged, diminished or radiologically absent 206 
through failure or loss of appropriate vascularization resulting in smaller or missing bones. More 207 
elementally, such careful dissections and/or detailed imaging of human malformed limbs has 208 
revealed that such limb malformations possess an arterial pattern typical of embryonic stages 209 
and/or missing or misplaced vessels consistent with a failure of correct vascularization of the 210 
involved bone [12, 17, 22, 23, 32, 33, 34, 35, 37]. Failure of arteries to develop to vascularize the 211 
condensing cartilage precursor of the long bones will have intuitively resulted in the loss or 212 
reduction in the length of the long bone (Figure 4). For example, late arterial invasion of the tibia 213 
has been linked to the shortening and bending of the bone due to a delayed formation of the 214 
perichrondral ring, which encases the diaphysis (growth plate) of the long bones [33, 40]. 215 
Likewise, in limbs with PFFD, a significantly reduced arterial supply to the femur has been 216 
identified that is linked to femoral shortening [32]. Further, the distal 2/3 of the fibula is supplied 217 
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by the fibular (peroneal) artery, whilst the proximal 1/3 is supplied by the anterior tibial artery; 218 
thus, loss of either one of these vessels during fibula differentiation might result in fibula 219 
deficiency or diminution [9, 10, 12].  Finally, in the upper limb, loss of the radial artery has been 220 
purportedly linked to the underlying cause of radial aplasia (loss of the radius) [36].  221 
 222 
The failure of arteries to vascularize their respective bony precursors could explain many limb 223 
abnormalities including long bone loss, long bone bending as well as changes to digital patterns 224 
due to the loss of or shortening of the long bones. Given the arterial transition occurs as the 225 
bones have been specified and are starting to condense, the damage is thus, post-specification.  226 
 227 
What could cause the blood vessels to not form correctly, or fail to transit to the adult state or 228 
simply mispattern to cause limb anomalies? 229 
 230 
Molecular changes resulting in vascular disruption 231 
We know there are many human (and animal) limb defects associated with genetic mutations and 232 
signaling changes [6, 7]; perhaps these are caused in early development before specification of 233 
the bony elements or perhaps the resulting signaling changes alters vascularization of the 234 
developing limbs and the arterial transition and branching events? For example, in some patients 235 
with Holt-Oram Syndrome, a condition caused by a mutation in the gene Tbx5, upper limb 236 
reduction ranging in severity from loss of the thumb to phocomelia is seen [41]. A reduced 237 
peripheral vasculature in the affected limb/s has been reported in some patients [42]. Whether 238 
this is secondary to the limb malformation or could actually be responsible is unclear. 239 
 240 
Furthermore, recent work in animal models does suggest that failure of the forming bones to 241 
receive the correct vascularization at the right time does result in bone outgrowth failure. For 242 
example, a study where the neurotrophic factor, TrkA, essential to direct innervation and 243 
promote vascularization of the outgrowing bone, when knocked out in mouse embryos result in 244 
smaller bones in the limb due to a failure of vascularization of the bone [43]. Moreover, 245 
molecular signals essential for blood vessel formation and identity, such as the Ephrins, members 246 
of the Notch signaling pathway and members of the VEGF signaling pathway, are also essential 247 
for proper bone vascularisation [44, 45]. Thus, if molecular signals fail to induce correct 248 
vascularization of the forming bones, those bones do not form correctly.  249 
 250 
Trauma during pregnancy leading to arterial dysgenesis or vascular disruption 251 
-Occlusion of vessels 252 
Pregnancy significantly increases the chances of thrombotic events, frequently due to changes in 253 
blood coagulation whilst pregnancy is ongoing to prevent excess blood loss during pregnancy 254 
and childbirth [46]. However, this could also increase the chance of thrombotic events in the 255 
embryo. Some studies have proposed that vessel occlusion in the embryo through thrombi 256 
through the placenta or from the heart or injured tissue could result in tissue damage leading to 257 
malformation in humans [25, 27, 47, 48] and in animals [29, 31, 49].  258 
 259 
Indeed, one study in chicken embryos demonstrated that following occlusion of the carotid 260 
arteries severe brain anomalies such as anencephaly could be induced [49]. The study simply 261 
demonstrates that the carotid arteries were missing and tissue distal to the occlusion never 262 





Hemorrhage early in embryogenesis has also been linked in the genesis of malformations [50-267 
52]. Indeed localized hematomas have been observed in spontaneously aborted human fetuses, 268 
without determination that the hematoma was the cause of the fetal death [53]. In addition focal 269 
hematomas or hemangiomas have been observed on the forehead of thalidomide damaged babies 270 
[51, 54, 55]. Hemorrhage induction in rat embryos through injection of drugs like aspirin [56] or 271 
through amniocentesis [57] has been shown to result in limb defects in rat fetuses, where 272 
increased uterine contractions in a smaller uterine space are purported to have caused damage, 273 
specifically via hemorrhaging, in the forming hand and footplates of the embryos; this can result 274 
in constriction bands, loss of digits and acrosyndactyly [57]. Similarly, in chicken embryos, after 275 
vessels were physically injured resulting in hemorrhage, embryonic development was impaired 276 
[52]. The hemorrhage most likely initiated a failure of differentiation of mesoderm and interfered 277 
with signaling processes, resulting in such dysmorphologies. 278 
 279 
These events can result from external influences such as drug exposure (see next section) or 280 
through trauma, even from procedures that are seemingly simple. As, for example, 281 
amniocentesis, a method of analysis of the chromosome karyotype of the embryo/fetus involves 282 
aspirating amniotic fluid. It can lead to uterine constriction due to the reduction in amniotic fluid 283 
volume, resulting in damage to the limbs. Moreover, chorionic villus sampling, also used as a 284 
prenatal diagnostic tool, has been linked to terminal transverse limb malformations through 285 
disruptive vascular events, through hemorrhaging or cell death/tissue loss and/or hemangioma 286 
formation [58]. Although these events rarely occur, and most procedures occur without untoward 287 
consequences, these studies do highlight the need to monitor pregnancies without reduction of 288 
amniotic fluid to minimise damage to the extremities if uterine constriction does occur. In 289 
addition, placental damage itself from vascular insufficiency or from trauma to the uterus could 290 
result in thrombi that occlude vessels or cause hemorraging in the placenta restricting blood flow 291 
to the embryo potentially resulting in growth retardation of embryonic tissues [58]. 292 
 293 
Drugs taken during pregnancy leading to vascular disruption 294 
-Thalidomide 295 
Of course, environmental influences can also cause vascular anomalies in embryos, these include 296 
exposure to drugs like phenytoin,  cocaine and valproate [58-60]. Perhaps the most infamous are 297 
thalidomide and more recently, misoprostol. 298 
 299 
Thalidomide has been shown to be antiangiogenic in rabbit and rodent cornea assays [61, 62] and 300 
in chicken and zebrafish embryos [21, 63-66]. Indeed, the drugs antiangiogenic action is widely 301 
viewed as part of the key in the drugs teratogenic actions where the drug may target angiogenic, 302 
smooth muscle negative vessels resulting in their loss, or preventing them to transition to an 303 
adult state as well as then resulting in changes in molecular signaling pathways and ultimately 304 
tissue loss/malformation [67- 69].  305 
 306 
It is of further interest to note that several studies in thalidomide survivors (children and adult) 307 
with limb anomalies, have reported cardiovascular malformations and vascular changes and/or 308 
missing vessels in the limbs which might help explain the damage [70, 71].  309 
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 310 
The hypothesis is that thalidomide induces vessel loss or may interfere with the vascular 311 
transition which could lead to localized cell death resulting in missing or lost tissue, resulting in 312 
bony elements being shorter or lost [67, 68]. As the time sensitive window of thalidomide 313 
embryopathy is day 20-36 after fertilization (day 34-50 after the last menstrual cycle), when 314 
vascular transition of the limbs is occurring and when proximal bony elements are condensing 315 
and starting to differentiate (Figure 2A), inhibition of vascularization could well result in the 316 
deficiency of or shortening of the forming long bones which could vary depending on the arterial 317 
alterations occurring at that time [67, 68].  318 
 319 
-Misoprostol 320 
Misoprostol is a synthetic analog of Prostaglandin E1 and used to prevent gastric side effects 321 
caused by nonsteroidal anti-inflammatory drugs. It also causes endometrial bleeding and uterine 322 
contractions and so has been used as an abortificient, particularly in Brazil [58, 72]. Sadly, it has 323 
been shown to cause birth defects in children when the drug was used improperly [58]. The 324 
injuries observed in such affected infants appears similar to the damage seen in thalidomide 325 
damaged children [73] with limbs, facial and internal organs all affected. Moreover, the drug is 326 
thought to cause vascular disruption in tissues  likely due to increased uterine contractions that 327 
Misoprostol induces (as part of the abortifacient process) resulting in hypoperfusion of the 328 
embryo/fetus and blood entrapment/hemorrhaging [58, 74, 75]. 329 
 330 
Several other agents, including Valproic acid, can also cause vascular anomalies during 331 
embryonic development. In chicken embryos valproate exposure produces a range of defects 332 
similar to those in humans including neural and cardiac defects [76] and limb reduction defects 333 
[77]. Furthermore, recent work demonstrated that popular anti-cancer antiangiogenic agents, 334 
including Sunitinib, Sorafenib, Everolimus are also teratogenic and can cause a range of defects 335 
including limb anomalies [78]. 336 
 337 
Conclusion 338 
Blood vessels in the developing embryonic limbs change rapidly to accommodate the outgrowth 339 
of the limbs and the differentiation processes needed to allow the complex combinations of 340 
tissues to form. The morphology of the bony pattern of the limbs evolves as vascular pattern is 341 
transforming to a mature, adult-like state. Noxious events which prevent the proper arterial 342 
transitioning, can prevent vessels from correctly invading the forming precursors of the bones 343 
resulting in a variety of defects. Similarly, injury resulting from hemorrhage, uterine constriction, 344 
physical damage, drug exposure, molecular signalling failure or interference could also result in 345 
such vascular changes. Such loss or inhibition of vessels or disruption of blood flow results in 346 
poorly perfused tissues and bones leading to deficiency and/or malformation. As arterial 347 
transition and bone formation are occurring at similar time points in embryonic development, 348 
such vascular damage could explain a variety of limb anomalies. 349 
 350 
Our understanding of the normal mechanisms underlying and controlling angiogenesis and how 351 
the developing vasculature influences normal limb development, particularly the underlying 352 
molecular signaling events, remains unclear.  Indeed, recent models of pattern formation in limb 353 
development have seemed solely focused on molecular mechanisms [8, 79, 80] yet largely ignore 354 
 9 
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 572 
Figure Legends 573 
Figure 1 574 
Vasculogenesis and Angiogenesis 575 
Endothelial cell precursors coalesce to form a clump of cells which then form a lumen to form 576 
the primitive vessels in a process termed vasculogenesis – this is the de novo formation of the 577 
first vessels. The vessels undergo angiogenesis following signal stimulation which result in 578 
endothelial cell proliferation and migration. Once vessels have reached their target they can 579 
recruit smooth muscle cells to become stable and to mature. In order to undergo further 580 
angiogenesis the vascular smooth muscle coat needs to be shed. Some of the signalling 581 
molecules involved in angiogenesis and vessel maintenance are detailed. 582 
Figure reproduced with permission from N. Vargesson, Vascularisation of the developing chick 583 
limb bud: role of the TGFbeta signalling pathway. J. Anat. 202 (2003) 93-103. [1] 584 
Figure 2 585 
Limb development and limb vascularisation 586 
A.Generalised schematic of limb development. In the early limb bud Fgf8 is released from the 587 
the apical ectodermal ridge (AER) and signals to the zone of polarising activity (ZPA) to 588 
produce Shh which then establishes and maintains a feedback loop to allow mesenchymal cell 589 
proliferation and limb bud outgrowth. As limb development proceeds differentiation of the bones 590 
of the limb starts in a proximal to distal manner with the humerus forming first. The AER-ZPA 591 
feedback loop is maintained and induces many other signals involved in limb formation and 592 
patterning including Hox genes which also play a role in patterning the different bony elements. 593 
B.Vascularisation of the developing chicken embryo forelimb. Upper panels are ink injected 594 
limb buds at different stages of development to highlight the forming and rapidly changing 595 
vasculature. The numbers refer to the stage of development of the embryo: 18 = day 2.5; 23 = 596 
day 4; 26 = day 5; 30 = day 7. The limb bud grows out rapidly and the vasculture changes 597 
rapidly to accommodate the outgrowth. Arrows demarcate the avascular zone between the 598 
angiogenic vessels and the limb tip. Bottom panel are confocal microscope images of limbs at 599 
the equivalent stages as the corresponding upper panel showing an antibody stain for vascular 600 
smooth muscle actin. This highlights that the subclavian artery is the first and only artery to 601 
recruit smooth muscle at around day 5 of development and by day 7 of development, the whole 602 
of the subclavian artery and the proximal parts of the radial and ulnar arteries have smooth 603 
muscle but very few other vessels are smooth muscle positive at this point. The recruitment of 604 
smooth muscle to the subclavian artery coincides with the visualisation of the humerus 605 
proximally. The recruitment of smooth muscle to the radial and ulnar arteries coincides with the 606 
appearance of the radius and ulna condensations. Vascular smooth muscle negative vessels are 607 
more angiogenic and permit rapid change to accommodate the outgrowing limb bud, however 608 
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they are also weaker and more susceptible to teratogenic insults. The black asterisk in the 609 
handplate denotes vessel regression in the future areas where the digits will condense and form. 610 
Figure A reproduced with modification from N. Vargesson, Thalidomide-induced teratogenesis: 611 
history and mechanisms. Birth Defects Res C Embryo Today. 105 (2015) 140-156. [68] 612 
Figure B reproduced with permission from N. Vargesson, Vascularisation of the developing 613 
chick limb bud: role of the TGFbeta signalling pathway. J. Anat. 202 (2003) 93-103. [1] 614 
 615 
Figure 3 616 
Embryo to adult arterial transition 617 
A Upper limb arterial transition. The vessel capillary plexus network seen in the very early limb 618 
bud around Stage 12 (30 days) disappears and differentiates into the adult pattern following the 619 
appearance of the skeletal elements. 620 
Stage’s refer to the Carnegie staging system of human embryo development (O’Rahilly and 621 
Muller, 1987). Stage 12, 30 days (approx. 4.3 weeks); Stage 13, 32 days (approx. 4.6 weeks); 622 
Stage 14, 33 days (approx. 4.7 weeks); Stage 15, 36 days (approx. 5.1 weeks); Stage 17, 41 days 623 
(approx. 5.9 weeks); Stage 18, 44 days (approx. 6.3 weeks) and Stage 21, 51 days (approx. 7.3 624 
weeks). 625 
s, subclavian artery; a, axillary artery; b, brachial artery; r, radial artery; u, ulnar artery; ai, 626 
anterior interosseous; H, humerus; U, ulna; R, radius. 627 
B Lower limb arterial transition. 12mm stage (approx. 5.4 weeks), 14mm stage (approx 5.7 628 
weeks), 18mm stage (approx. 6.3 days), 22mm stage (approx. 6.8 weeks), Adult stage (after 7th 629 
week). 630 
12mm stage of development a single-axis artery traverses the leg bud. By 14mm two arteries (TP 631 
and PPS) originate posteriorly and the RPC branches anteriorly off the Interossea artery. By 632 
18mm the anterior tibial artery develops as a continuation of the RPC. A branch (the RC) 633 
develops off the PPS and anastomoses with the interossea artery. Five arteries now traverse the 634 
forming leg. At 22mm stage of development there is regression of the distal part of the peronea 635 
posterior superficialis and of the proximal part of the interossea artery. Note the presence of the 636 
fibular (peroneal) artery (PE) which has formed from parts of the Axial, PPS, RC arteries. By the 637 
7
th
 week the adult pattern has emerged with the regression of the popliteal profunda. 638 
Embryonic arteries: PP popliteal profunda; PS popliteal superficialis; PPS peronea posterior 639 
superficialis; I interossea; RC ramus communicans inferior; RPC ramus perforans cruris; IS 640 
ischiatic; TP tibialis posterior superficailis; P popliteal; PT posterior tibial; PE peroneal; AT 641 
anterior tibial; RT recurrent tibial. 642 
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Muscles: MP popliteus; MTP tibilis posterior; MFH flexor halluces. 643 
Figure A reproduced with permission from M. Rodriguez-Niedenfuhr, G. J. Burton, J. Deu, J. R. 644 
Sanudo, Development of the arterial pattern in the upper limb of staged human embryos: normal 645 
development and anatomic variations. J. Anat. 199 (2001) 407-417. [13] 646 
Figure B reproduced with permission from E. M. Levinsohn, D. R. Hootnick, D. S. Packard Jr. 647 
Consistent arterial abnormalities associated with a variety of congenital malformations of the 648 
human lower limb. Invest Radiol. 26 (1991) 364-373. [12] 649 
 650 
Figure 4 651 
Altered/missing arterial patterns in legs with abnormalities 652 
Drawings of arterial patterns in A. Normal Limb; B. Limb with skeletal dysplasia with 653 
abnormally short fibula – the anterior tibial and fibular (peroneal) arteries are absent and 654 
functional embryonic arteries (I, PRS, RC) remain; C. Limb with skeletal dysplasia and absent 655 
fibula with midline metatarsal dysplasia. Anterior tibial and fibular (peroneal) arteries are absent. 656 
Functional embryonic arteries (I, RC) remain; D. Clubfoot, the anterior tibial artery is reduced. A 657 
functional embryonic artery (PPS) is present. 658 
These drawings are summary diagrams made following dissection of human tissues to analyse 659 
the vessel pattern changes and the causation of the deformity [12, 17, 23, 33, 37]. 660 
Figure A-D from D. R. Hootnick, D. S. Packard Jr, E. M. Levinsohn, R. Constantine, 661 
Postoperative necrosis in Clubfoot: recent findings and review. Orthopedics International Edition 662 
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